ANS

Quinn Karylle Fuentes · 28問 · 2年前

通報

問題一覧

A motor function and travels from brain to periphery

Efferent.

A sensory and travels from periphery to brain.

Afferent.

What is the response in stimulus

Irritation.

Neuro terminal also know as

Axon terminal.

It is the protection of axon

Mylein sheath.

Damage in mylein sheath called as

Multiple scherossis.

What are the 2 types of neuron

Action state, Resting state

Increase neuronal activity

Action.

SPO is applicable in?

Action state

SPO standa for?

Sodium in Potassium out

Decrease neuronal action.

Resting state.

PISO is applicable in?

Resting state

PISO stands for?

Potassium in Sodium out

A chemical messengers of neuron

Neurotransmitter

Presynapse functions are?

Maintain normal balance, Do not cause action potential but NFE, Pre sympathetic receptors

Presynapse functions are?

Synthesis, Storage, Release of neuron

Negative feedback affect which lower the synthesis and lower its release

NFE

This is where mjority of the receptors located

Post synpase.

It create potential at pharmaceutical response

Post synapse

Constrict the pupil

Miosis

Dilate the pupil

Mydriasis

In brain adrenaline rush can cause?

Increase mental fear

In lungs the adrenaline rush can cause?

Bronchodilation

It produce in adrenal gland

Norepinephrine

What is the precursor of corticosteroids

Cortisol.

Catecholamines also know as?

Orthodihydroxybenzene, 1,2- dihyrdoxybenzene

What is the precursor of catecholamines

Tyrosine.

An increase sedation of catecholamine can produce cyst (bukol) T/F

True

It control involuntary muscle

White matter

Myleinated function

White matter

Nerve cell and branching of dendrites

Grey matter

Controlled sense of body

Grey matter.

It control the involuntary muscle

Autonomic

Movement of voluntarily muscle

Somatic

What are under od autonomic

Sympathetic, Parasympathetic, Enteric CNS

What are the functions of Sympathetic

increase heart rate, Bronchodilation, Also know as fight or flight, AKA adrenaline rush

What are the examples of Sympathetic

Trauma, Fear, Cold exercise

What is the neurotransmitter of Sympathetic

Catecholamines.

What are the receptors of catecholamines

Alpha, Beta, Dopamine

Sympathetic also know as

Adrenergic

What are the functions of paraSympathetic

Bronchoconstriction, Decrease heart rate, Rest of digest

Parasympathetic has a opposite function of Sympathetic (

True

What is the neurotransmitter of Parasympathetic

Acetylcholine

What are the receptors of acetylcholine

Nicotinic, Muscarinic

Contractions of collon or large intestine

Enteric cns

A rate limiting step

Tyrosine

VMA stands dor vanillyn mandelic acid (T/F)

True

Where did tyrosine enter?

Sodium

If tyrosine undergo in tyrosine hydrogenase it will produce?

Dopa.

If Dopa undergo in Dopa hydrogenase it will produce?

Dopamine.

If Dopamine undergo in Dopamine -3-hydroxylasw it will produce?

Dopamine and epinephrine produce a release (True/False)

True.

What are the under of release

Bind, inactivator

Tyrosine is a rate limiting step

True

What are the stress hormones.

Catecholamines, Cortisol.

first catecholamine to be synthesized in the biosynthesis.

Dopamine.

What is the effect in the heart in SNS

Tachycardia.

What is the effect in the heart in PNS

Bradycardia.

What is the effect in the Pupil in SNS

Mydriasis

What is the effect in the pupil in PNS

Miosis

What is the effect in the Bronchi in SNS

Relaxation

What is the effect in the Bronchi in PNS

Construction.

What is the effect in the bladder in SNS and PNS

Contraction.

What is the effect in the bladder sphincters in SNS and PNS

Relaxation.

What is the effect in the Interstenal wall in SNS and PNS

Contractions.

What is the effect in the intertenal sphincter in SNS

Hyperdyrosis.

What is the effect in the intersinal sphincter in PNS

Relaxation.

What is the effect in the apocrine in SNS and PNS

Anhydrosis.

What is the effect in the Ecrine in SNS

Anhydrosis.

What is the effect in the Ecrine in PNS

Hyperhydrosis.

First recognized ganglionic blocker

Tetraethammonium

First effective drug for management of hypertension. It is now rarely used for HTN due to lack of selectivity compared to newer agent

Hexamethonium.

-An analog of hexamethonium effective as neuromuscular depolarizing blocking agent.

Decamethonium.

-secondary amine studied for possible use in reducing nicotine craving in patients attempting to quit smoking

Mecamylamine

-inactive orally and given as IV infusion, short-acting ganglion blocker, occasionally used in the treatment of hypertensive emergencies

Trimethaphan

If norepinephrine under go to Catechol-O methyltransferase it will yields

Normetanephrine.

If Dihydroxymandelic under go to Catechol-O methyltransferase it will yields

Vanillylmandelic acid.

If Normetanephrine under go to Monoamine oxidase is will yeild as?

Vanillylmandellic acid.

If metanephrine under go to Monoamine oxidase is will yeild as?

Vanillylmandellic acid.

If Norephrine under go to Monoamine oxidase is will yeild as?

Dihydroxymandelic acid.

If Epinephrine under go to Monoamine oxidase is will yeild as?

Dihydroxymandelic acid.

If Epinephrine under go to Catechol-O methyltransferase it will yields

Metanephrine.

This final product is measured in urine and plasma

Vanillylmandelic acid.

excreted using a transport mechanism called .

Exocytosis

axon terminal makes contact with other neurons

Neurotransmission.

It interacts with specialized receptors.

Neurotransmitter.

initiation of movement, coordination of -movement -temperature - touch -vision -hearing, -judgment, + reasoning, problem solving, emotions, and learning.

Cerebrum.

largest part of the brain which contains the cerebral cortex

Telencephalon.

Activated by aCH; Muscle contraction.

Nicotinic muscular.

Ganglia bith SNS and PNS in the pre-ganglionic fiber.

Nicotinic neutral.

management for myasthenia gravis

Pyridoxamine, Neostigmine, Ambenonium

Mgt for atropine toxicity

Neostigmine

Mgt for neuromuscular blocker toxicity

Neostigmine, Endophonium.

Useful for glaucoma

Pilocarpine, Ecothiopate, Carbachol., Demecarium.

For non obstructive illeus

Physostigmine

Smoking sensation

Nicotinic, Varenictine.

Cell structure.

Cell structure.

28問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Electrolytes and non electrolytes

Electrolytes and non electrolytes

29問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

POST LAB (EXP 4)

POST LAB (EXP 4)

38問 • 2年前

Density and specific gravity

Density and specific gravity

Quinn Karylle Fuentes · 18問 · 2年前

FORCES OF ATTRACTION

FORCES OF ATTRACTION

18問 • 2年前

Quinn Karylle Fuentes · 63問 · 2年前

Microbial growth

Microbial growth

63問 • 2年前

Quinn Karylle Fuentes · 61問 · 2年前

Introduction.

Introduction.

61問 • 2年前

Quinn Karylle Fuentes · 97問 · 2年前

Microbial control.

Microbial control.

97問 • 2年前

Quinn Karylle Fuentes · 100問 · 2年前

States of matter

States of matter

100問 • 2年前

Quinn Karylle Fuentes · 86問 · 2年前

Introduction.

Introduction.

86問 • 2年前

Quinn Karylle Fuentes · 77問 · 2年前

Drug development.

Drug development.

77問 • 2年前

Quinn Karylle Fuentes · 9問 · 2年前

CGMP

CGMP

9問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Pharmaceutical ingredients.

Pharmaceutical ingredients.

24問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Powdered & granules

Powdered & granules

43問 • 2年前

Quinn Karylle Fuentes · 24問 · 2年前

Capsule.

Capsule.

24問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Tablets.

Tablets.

23問 • 2年前

Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前

Calculatiom of dose

Calculatiom of dose

3回閲覧 • 66問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

Postlab 5&6

Postlab 5&6

29問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

COLLIGATIVE PROPERTIES.

COLLIGATIVE PROPERTIES.

33問 • 2年前

Quinn Karylle Fuentes · 69問 · 2年前

SEMI SOLID

SEMI SOLID

69問 • 2年前

Quinn Karylle Fuentes · 60問 · 2年前

Basic immunology

Basic immunology

60問 • 2年前

Quinn Karylle Fuentes · 62問 · 2年前

Basic immunology (2)

Basic immunology (2)

62問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

Transdermal

Transdermal

44問 • 2年前

Quinn Karylle Fuentes · 43問 · 2年前

Distribution.

Distribution.

43問 • 2年前

Quinn Karylle Fuentes · 65問 · 2年前

Infectious disease.

Infectious disease.

65問 • 2年前

Quinn Karylle Fuentes · 79問 · 2年前

Infectious diseases (2)

Infectious diseases (2)

79問 • 2年前

Gram positive ( Bacteriology)

Gram positive ( Bacteriology)

All topic. ( Compressed.)

All topic. ( Compressed.)

Quinn Karylle Fuentes · 30問 · 2年前

All topic ( Compressed)

All topic ( Compressed)

30問 • 2年前

Quinn Karylle Fuentes · 13問 · 2年前

All topics (compressed)

All topics (compressed)

13問 • 2年前

Quinn Karylle Fuentes · 28問 · 2年前

Exercise 6 ; Isotonic solution.

Exercise 6 ; Isotonic solution.

28問 • 2年前

Quinn Karylle Fuentes · 16問 · 2年前

Exercise 5 : Buffers.

Exercise 5 : Buffers.

16問 • 2年前

Quinn Karylle Fuentes · 26問 · 2年前

Exercise 7 : Factors affecting solubility.

Exercise 7 : Factors affecting solubility.

26問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

Experiment 8: Disintegration.

Experiment 8: Disintegration.

23問 • 2年前

Experiment 9 ; Interfacial phenomenon and surface tension.

Experiment 9 ; Interfacial phenomenon and surface tension.

EXP 9 : Aromatic ammonia spirit.

EXP 9 : Aromatic ammonia spirit.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.

Quinn Karylle Fuentes · 20問 · 2年前

EXP 12: ACACIA MUCILAGE

EXP 12: ACACIA MUCILAGE

20問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

EXP13&14 : Starch and Barrium sulfate.

EXP13&14 : Starch and Barrium sulfate.

33問 • 2年前

Quinn Karylle Fuentes · 37問 · 2年前

EXP 15 : Liquid petroleum emulsion 1.0

EXP 15 : Liquid petroleum emulsion 1.0

37問 • 2年前

Quinn Karylle Fuentes · 23問 · 2年前

EXP 15: Liquid petroleum emulsion 1.1

EXP 15: Liquid petroleum emulsion 1.1

23問 • 2年前

Enterobacteriaceae

Enterobacteriaceae

Quinn Karylle Fuentes · 28問 · 2年前

Enterobacteriaceae.

Enterobacteriaceae.

28問 • 2年前

Quinn Karylle Fuentes · 31問 · 2年前

LIQUID DOSAGE FORM 1.0

LIQUID DOSAGE FORM 1.0

31問 • 2年前

Quinn Karylle Fuentes · 12問 · 2年前

Liquid dosage form

Liquid dosage form

12問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

MICROMERITICS 1.0

MICROMERITICS 1.0

44問 • 2年前

Quinn Karylle Fuentes · 22問 · 2年前

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS

22問 • 2年前

Quinn Karylle Fuentes · 40問 · 2年前

EXP 8 : KIRBY-BAUER TECHNIQUE

EXP 8 : KIRBY-BAUER TECHNIQUE

40問 • 2年前

Quinn Karylle Fuentes · 29問 · 2年前

EXP 9: STAPHYLOCOCCI

EXP 9: STAPHYLOCOCCI

29問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug incompatibilities.

Drug incompatibilities.

41問 • 2年前

Quinn Karylle Fuentes · 41問 · 2年前

Drug compatibilities.

Drug compatibilities.

41問 • 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

Quinn Karylle Fuentes · 30問 · 2年前

BACTERIOLOGY 3

BACTERIOLOGY 3

30問 • 2年前

SUSPENSION.

SUSPENSION.

Quinn Karylle Fuentes · 40問 · 2年前

Colloidal.

Colloidal.

40問 • 2年前

Quinn Karylle Fuentes · 38問 · 2年前

BACTERIOLOGY 4 (Rickettsia)

BACTERIOLOGY 4 (Rickettsia)

38問 • 2年前

Quinn Karylle Fuentes · 44問 · 2年前

BACTERIOLOGY.

BACTERIOLOGY.

44問 • 2年前

Quinn Karylle Fuentes · 32問 · 2年前

Emulsion.

Emulsion.

32問 • 2年前

Quinn Karylle Fuentes · 42問 · 2年前

EMULSION

EMULSION

42問 • 2年前

Quinn Karylle Fuentes · 36問 · 2年前

MEDICAL RELATED PROBLEMS.

MEDICAL RELATED PROBLEMS.

36問 • 2年前

Quinn Karylle Fuentes · 33問 · 2年前

MEDICATION RELATED PROBLEMS.

MEDICATION RELATED PROBLEMS.

33問 • 2年前

Quinn Karylle Fuentes · 30問 · 2年前

Mycology.

Mycology.

30問 • 2年前

Mycology 2.0

Mycology 2.0

Quinn Karylle Fuentes · 15問 · 2年前

15問 • 2年前

Quinn Karylle Fuentes · 25問 · 2年前

ppr

ppr

25問 • 2年前

Quinn Karylle Fuentes · 20問 · 2年前

MEDICAL DEVICES.

MEDICAL DEVICES.

20問 • 2年前

Quinn Karylle Fuentes · 86問 · 2年前

Pharmacokinetics. (1.0)

Pharmacokinetics. (1.0)

86問 • 2年前

Quinn Karylle Fuentes · 100問 · 2年前

Pharmacokinetics (1.1)

Pharmacokinetics (1.1)

100問 • 2年前

Quinn Karylle Fuentes · 19問 · 2年前

Pharmacokinetics (1.2)

Pharmacokinetics (1.2)

19問 • 2年前

Quinn Karylle Fuentes · 17問 · 2年前

Introduction.

Introduction.

17問 • 2年前

Quinn Karylle Fuentes · 76問 · 2年前

Introduction of biochemistry

Introduction of biochemistry

76問 • 2年前

Quinn Karylle Fuentes · 56問 · 2年前

Intro medicanal chemistry.

Intro medicanal chemistry.

56問 • 2年前

Quinn Karylle Fuentes · 75問 · 2年前

Carbohydrates

Carbohydrates

75問 • 2年前

Quinn Karylle Fuentes · 31問 · 2年前

Carbohydrates 1.1

Carbohydrates 1.1

31問 • 2年前

Quinn Karylle Fuentes · 56問 · 2年前

Detect and quality variation.

Detect and quality variation.

56問 • 2年前

Quinn Karylle Fuentes · 98問 · 2年前

INTRODUCTION

INTRODUCTION

98問 • 2年前

Quinn Karylle Fuentes · 15問 · 2年前

lab (1-2)

lab (1-2)

15問 • 2年前

Quinn Karylle Fuentes · 14問 · 2年前

lab 1-2

lab 1-2

14問 • 2年前

Pharmaceutical chemistry.

Pharmaceutical chemistry.

Pharmaceutical chemistry 1.1

Pharmaceutical chemistry 1.1

Quinn Karylle Fuentes · 39問 · 2年前

Unit 3.

Unit 3.

39問 • 2年前

Quinn Karylle Fuentes · 70問 · 2年前

Histamin and kinins

Histamin and kinins

70問 • 2年前

PUD.

PUD.

Quinn Karylle Fuentes · 61問 · 2年前

61問 • 2年前

Quinn Karylle Fuentes · 67問 · 2年前

Lipids.

Lipids.

67問 • 2年前

Quinn Karylle Fuentes · 71問 · 2年前

lipids.

lipids.

71問 • 2年前

Quinn Karylle Fuentes · 93問 · 2年前

LAB ✨

LAB ✨

93問 • 2年前

Quinn Karylle Fuentes · 87問 · 2年前

Drug discovery.

Drug discovery.

87問 • 2年前

Quinn Karylle Fuentes · 13問 · 2年前

disease of lipids.

disease of lipids.

13問 • 2年前

Quinn Karylle Fuentes · 57問 · 2年前

Intro (identify structure)

Intro (identify structure)

57問 • 2年前

Quinn Karylle Fuentes · 98問 · 2年前

Carbohydrates

Carbohydrates

98問 • 2年前

Quinn Karylle Fuentes · 96問 · 2年前

Dynamic.

Dynamic.

96問 • 2年前

Quinn Karylle Fuentes · 32問 · 2年前

Unit 1

Unit 1

32問 • 2年前